Slot R, Kester M, van Harten A, Jongbloed W, Bouwman F, Teunissen C, et al. ApoE and clusterin CSF levels influence associations between APOE genotype and changes in CSF tau, but not CSF Aβ42, levels in non-demented elderly. Neurobiol Aging. 2019;79:101-109 pubmed publisher

Rebholz S, Melchior J, Welge J, Remaley A, Davidson W, Woollett L. Effects of Multiple Freeze/Thaw Cycles on Measurements of Potential Novel Biomarkers Associated With Adverse Pregnancy Outcomes. J Clin Lab Med. 2017;2: pubmed publisher

Apro J, Parini P, Broijersén A, Angelin B, Rudling M. Levels of atherogenic lipoproteins are unexpectedly reduced in interstitial fluid from type 2 diabetes patients. J Lipid Res. 2015;56:1633-9 pubmed publisher

Bissig Choisat B, Wang L, Legras X, Saha P, Chen L, Bell P, et al. Development and rescue of human familial hypercholesterolaemia in a xenograft mouse model. Nat Commun. 2015;6:7339 pubmed publisher

Halley P, Kadakkuzha B, Faghihi M, Magistri M, Zeier Z, Khorkova O, et al. Regulation of the apolipoprotein gene cluster by a long noncoding RNA. Cell Rep. 2014;6:222-30 pubmed publisher

Miles R, Perry W, Haas J, Mosior M, N Cho M, Wang J, et al. Genome-wide screen for modulation of hepatic apolipoprotein A-I (ApoA-I) secretion. J Biol Chem. 2013;288:6386-96 pubmed publisher

Wang Y, Snel M, Jonker J, Hammer S, Lamb H, de Roos A, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases plasma CETP and increases apolipoprotein AI levels without improving the cholesterol efflux properties of HDL. Diabetes Care. 2011;34:2576-80 pubmed publisher